Literature DB >> 6651699

Optimizing the enzyme-linked immunosorbent assay for evaluating immunity of chickens to Newcastle disease.

L A Miers, R A Bankowski, Y C Zee.   

Abstract

Experiments employing the various steps and reagents used in the enzyme-linked immunosorbent assay (ELISA) were conducted to produce an ELISA with the highest sensitivity and specificity possible for detecting Newcastle disease antibodies in chicken sera. Of the four types of antigen tested, crude antigen gave inconsistent results. However, an alcohol-precipitated antigen prepared from infectious allantoic-amniotic fluids was as satisfactory as more highly purified virus preparations. Other factors found to be extremely important were a 0.5M concentration of NaCl in the diluent and wash solutions used in the procedure, and a pH of 13 for sensitizing solution for maximum specific binding of the antigen to the microplate plastic wells. A comparison was made between the hemagglutination-inhibition (HI) titers of 550 known chicken sera and the corresponding ELISA values. Although the ELISA is much more sensitive than the HI test, there was a general but not a direct correlation between the two tests. The ELISA did not give more information than the HI test concerning protection against an NDV-induced drop in egg production. Preliminary observations indicated that this ELISA procedure is also applicable for turkey sera.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6651699

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  9 in total

1.  Rapid serological profiling by an immunocomb-based dot-enzyme-linked immunosorbent test for three major poultry diseases.

Authors:  S Manoharan; M Parthiban; T G Prabhakar; G Ravikumar; A Koteeswaran; N D J Chandran; G Rajavelu
Journal:  Vet Res Commun       Date:  2004-05       Impact factor: 2.459

2.  An ELISA blocking test using a peroxidase-labelled anti-HN monoclonal antibody for the specific titration of antibodies to avian paramyxovirus type 1 (PMV1).

Authors:  V Jestin; M Cherbonnel; R L'Hospitalier; G Bennejean
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

3.  Characterization of French avian paramyxovirus type 1 (PMV 1) isolates with a Panel of monoclonal antibodies to the Ploufragan strain of Newcastle disease virus.

Authors:  V Jestin; M Cherbonnel; M Morin; M Guittet; G Bennejean
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

4.  Methanol-precipitated, detergent-treated Newcastle disease virus as an agar-gel precipitation test antigen.

Authors:  P Roy; A Koteeswaran; A T Venugopalan
Journal:  Trop Anim Health Prod       Date:  1997-02       Impact factor: 1.559

5.  Characterization of Newcastle disease virus isolates by reverse transcription PCR coupled to direct nucleotide sequencing and development of sequence database for pathotype prediction and molecular epidemiological analysis.

Authors:  B S Seal; D J King; J D Bennett
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

6.  Detecting Newcastle disease virus in combination of RT-PCR with red blood cell absorption.

Authors:  Jianzhong Yi; Chengqian Liu
Journal:  Virol J       Date:  2011-05-02       Impact factor: 4.099

7.  Engineered recombinant protein products of the avian paramyxovirus type-1 nucleocapsid and phosphoprotein genes for serological diagnosis.

Authors:  Na Zhao; Christian Grund; Martin Beer; Timm C Harder
Journal:  Virol J       Date:  2018-01-11       Impact factor: 4.099

8.  Prevalence of newcastle disease virus in broiler chickens (Gallus gallus) in Brazil.

Authors:  M A Orsi; L Doretto; S C A Camillo; D Reischak; S A M Ribeiro; A Ramazzoti; A O Mendonça; F R Spilki; M G Buzinaro; H L Ferreira; C W Arns
Journal:  Braz J Microbiol       Date:  2010-06-01       Impact factor: 2.476

9.  Detergent-treated Newcastle disease virus as an agar gel precipitin test antigen.

Authors:  J Gelb; C G Cianci
Journal:  Poult Sci       Date:  1987-05       Impact factor: 3.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.